# OnCo record kras-mutation-subtypes (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/kras-mutation-subtypes/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "kras-mutation-subtypes" ;
  schema:name "KRAS mutation subtypes (G12C, G12D, G12V)"@en ;
  schema:alternateName "G12C"@en, "G12D"@en, "G12V"@en, "G12R"@en, "G13D"@en, "Q61H"@en, "KRAS G12C"@en, "KRAS G12D"@en, "KRAS-mutant"@en, "KRAS-mutated"@en, "KRAS mutation"@en, "KRAS mutations"@en, "RAS-mutant"@en, "RAS mutation"@en, "RAS-mutated"@en, "non-G12C"@en, "pan-RAS"@en, "pan-KRAS"@en, "RAS(ON)"@en, "RAS(OFF)"@en, "RAS mutations"@en ;
  schema:description "KRAS, the most commonly mutated cancer gene, comes in flavours named by the exact amino acid change. G12C (common in smokers' lung cancer) was the first to get a drug; G12D dominates pancreatic and colorectal cancer and its inhibitors are arriving now."@en ;
  schema:url <https://onco.cc/terms/kras-mutation-subtypes/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/KRAS> ;
  schema:citation <https://en.wikipedia.org/wiki/KRAS> ;
  onco:related <https://onco.cc/terms/driver-mutation/>, <https://onco.cc/terms/wild-type/>, <https://onco.cc/terms/stk11-keap1/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kras-inhibitors/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/sotorasib/>, <https://onco.cc/drugs/adagrasib/> .